4 minute read
Gadgets
Stimulator to combat stress, anxiety, and sleep problems
With only 4 minutes a day and through stimulation of the vagus nerve, this device promises to be an aid in the prevention and treatment of stress-related psychiatric disorders.
Pulsetto is a powerful device for home use launched to activate the parasympathetic nervous system safely and without leaving home. Scientific evidence shows that vagus nerve stimulation has positive effects in the prevention and treatment of stress-related psychiatric disorders. The Pulsetto stimulator uses neuromodeling based technology to slow the heart rate, reduce stress responses, and instill calm throughout the body.
Respiratory muscle trainer to slow lung aging
OPUMP is the first intelligent breathing training device that aims to develop, improve, and maintain lung health through breathing exercises. This device helps people suffering from COPD, asthma, and other chronic respiratory diseases, as well as those who want to strengthen their respiratory muscles to delay natural aging. It includes training programs and measurement of respiratory strength, vital capacity, and anaerobic threshold.
OPUMP syncs to your smartphone to provide realtime guidance and tracking, it can also create beautiful songs from your breath.
U-Scan, the new miniature laboratory
In the form of a 90mm diameter round pill, U-Scan is a cartridge-based urine analysis device capable of detecting, measuring, and tracking multiple parameters found in urine.
By placing it in your toilet, U-Scan offers a status of body balance by monitoring and detecting potential diseases or medical conditions thanks to its more than 3,000 biomarkers. The device has the particularity of differentiating different types of urine from different people in the same family and even differentiating urine from other liquids. The company Withings expects to offer it to the market at a price of 499.95 euros in the second half of 2023.
Nowatch, the watch without a screen that does not mark the time
Developed in collaboration with Philips advanced technologies, Nowatch is the latest advancement in biotechnology focused on mental well-being.
Inlaid with gemstones instead of a display, Nowatch is a science-backed, technology-based holistic wellness device. Through its multisensors, it analyzes the activity of the sudoriferous glands and measures stress levels, as well as capturing biological data such as respiratory rate, heart rate, temperature, skin conductance, body movement, and oxygen in the blood. The whole device, the application, and the membership cost 427 euros. It has been on the market since mid2023.
Goodbye to post-workout pain
FDA-approved for muscle recovery and pain relief; Lumaflex Body Pro is the new wearable red light therapy device that promises to unlock peak athletic performance. The therapy relies on sending low-level wavelengths of red or near-infrared light through the skin to stimulate cell function. With just 10 minutes of use per day, Lumaflex Body Pro boosts physical performance, relieves chronic joint pain, and accelerates post-workout recovery. In addition, among its benefits are the production of collagen, better circulation, reduction of inflammation, and cell regeneration. Its price is $ 689.
Apple Vision Pro glasses, the new era of spatial computing
Apple’s first space operating system is about to hit the market and promises to be the most advanced augmented reality and virtual reality device ever made for consumption.
Without a mouse, keyboard, or touch screen, the glasses allow you to navigate and interact just by looking at the images transmitted to two micro-OLED screens with more than 23 million pixels for maximum resolution. To control the glasses, the device uses eye tracking, hand gestures, and voice recognition. Apple Vision glasses and its operating system, VisionOS, allow you to capture spatial images and videos in 3D and then relive the moment in an immersive way, generating the feeling of living in an alternative reality wherever you look. They will cost $3,499 and will be available in early 2024 only in the U.S.
